Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Clinical Breast Cancer
Published August 22, 2026
Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response in Triple-Negative Breast ...
September 13, 2026
Medspoke
Medspoke
European Journal of Cancer
Published September 9, 2026
00:00
--:--
Futibatinib after non-covalent FGFR inhibitors in FGFR2-rearranged intrahepatic cholangiocarcinom...
September 13, 2026
Share
Futibatinib after non-covalent FGFR inhibitors in FGFR2-rearranged intrahepatic cholangiocarcinoma: clinical activity and resistance patterns.
https://www.medspoke.co/channel_journal?id=785&tap_id=13847
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Blood Advances
Published August 20, 2026
Peripheral Blasts at Apheresis as a Risk Factor for Survival following Tisagenlecleucel in Childr...
September 12, 2026
Why are you reporting this TALK?
